Effect of Intermittent Hemodialysis Frequency on Metabolic Control in Acute Renal Failure.
Quantification of the prescribed and delivered doses of renal replacement therapy (RRT) in end-stage renal disease (ESRD) is now commonly performed, since recent data demonstrate a clear relationship between dialysis dose and outcome. In recent years, some of the quantification techniques developed for ESRD patients have been extended to the acute renal failure (ARF) setting. This extension has allowed the assessment of the specific effect of the frequency of intermittent hemodialysis (IHD) on delivered dialysis dose and metabolic control. In this review, after a discussion of the manner in which therapy prescription factors differ in the ARF and ESRD settings, the issue of the frequency of IHD in the ARF setting is explored.